Chasing Genzyme, AvroBio bags $60M to fund Fabry disease gene therapy trial
February 01, 2018 at 07:00 AM EST
The 30-employee company said Thursday that it had raised $60 million in new financing to help fund a mid-stage trial of an experimental gene therapy for Fabry disease.